Publikation: Prostacyclin in the cardiovascular system : new aspects and open questions
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
Several indications exist that prostacyclin (PGI(2)) release in the cardiovascular system might be affected by cyclooxygenase (COX)-2-specific inhibitors. This could reflect an inhibition of PGI(2) synthesis in the endothelium although in these cells mainly COX-1 is expressed. Inflammation and stress induce COX-2 in smooth muscle cells which could have happened in patients with cardiac diseases. Herein, we show that also cardiomyocytes contain PGI(2) synthase in intercalated discs as a third source of PGI(2) in the cardiovascular system. Another aim of this study was to explain the finding that PGI(2) synthase in lipopolysaccharide (LPS)-treated smooth muscle cells, in contrast to endothelial cells, is resistant to nitration and inhibition by peroxynitrite. By using redox cyclers, the nitration occurred and confirmed our previous hypothesis that a high peroxidative activity of such cells keeps peroxynitrite below the effective levels of 50 nM. Considering enhanced oxidative stress in aged vessels, we postulated and verified that endothelial dysfunction in aged vessels is due to nitration and inhibition of PGI(2) synthase. Such data underline the role of PGI(2) as a potent mediator for regaining and maintaining the normal resting state of cells in a COX-2 dependent fashion.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
KLUMPP, Georg, Stefan SCHILDKNECHT, Wolfgang NASTAINCZYK, Volker ULLRICH, Markus BACHSCHMID, 2005. Prostacyclin in the cardiovascular system : new aspects and open questions. In: Pharmacological Reports. 2005, 57(Suppl.), pp. 120-126. ISSN 1734-1140. eISSN 2299-5684BibTex
@article{Klumpp2005Prost-38759,
year={2005},
title={Prostacyclin in the cardiovascular system : new aspects and open questions},
number={Suppl.},
volume={57},
issn={1734-1140},
journal={Pharmacological Reports},
pages={120--126},
author={Klumpp, Georg and Schildknecht, Stefan and Nastainczyk, Wolfgang and Ullrich, Volker and Bachschmid, Markus}
}RDF
<rdf:RDF
xmlns:dcterms="http://purl.org/dc/terms/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
xmlns:bibo="http://purl.org/ontology/bibo/"
xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
xmlns:foaf="http://xmlns.com/foaf/0.1/"
xmlns:void="http://rdfs.org/ns/void#"
xmlns:xsd="http://www.w3.org/2001/XMLSchema#" >
<rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/38759">
<dc:creator>Bachschmid, Markus</dc:creator>
<dc:contributor>Ullrich, Volker</dc:contributor>
<dcterms:issued>2005</dcterms:issued>
<dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-05-05T16:02:32Z</dc:date>
<dc:creator>Schildknecht, Stefan</dc:creator>
<bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/38759"/>
<dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dc:creator>Ullrich, Volker</dc:creator>
<dc:language>eng</dc:language>
<dcterms:title>Prostacyclin in the cardiovascular system : new aspects and open questions</dcterms:title>
<dc:creator>Klumpp, Georg</dc:creator>
<foaf:homepage rdf:resource="http://localhost:8080/"/>
<dc:contributor>Schildknecht, Stefan</dc:contributor>
<dc:contributor>Bachschmid, Markus</dc:contributor>
<dcterms:abstract xml:lang="eng">Several indications exist that prostacyclin (PGI(2)) release in the cardiovascular system might be affected by cyclooxygenase (COX)-2-specific inhibitors. This could reflect an inhibition of PGI(2) synthesis in the endothelium although in these cells mainly COX-1 is expressed. Inflammation and stress induce COX-2 in smooth muscle cells which could have happened in patients with cardiac diseases. Herein, we show that also cardiomyocytes contain PGI(2) synthase in intercalated discs as a third source of PGI(2) in the cardiovascular system. Another aim of this study was to explain the finding that PGI(2) synthase in lipopolysaccharide (LPS)-treated smooth muscle cells, in contrast to endothelial cells, is resistant to nitration and inhibition by peroxynitrite. By using redox cyclers, the nitration occurred and confirmed our previous hypothesis that a high peroxidative activity of such cells keeps peroxynitrite below the effective levels of 50 nM. Considering enhanced oxidative stress in aged vessels, we postulated and verified that endothelial dysfunction in aged vessels is due to nitration and inhibition of PGI(2) synthase. Such data underline the role of PGI(2) as a potent mediator for regaining and maintaining the normal resting state of cells in a COX-2 dependent fashion.</dcterms:abstract>
<dc:creator>Nastainczyk, Wolfgang</dc:creator>
<dc:contributor>Klumpp, Georg</dc:contributor>
<dc:contributor>Nastainczyk, Wolfgang</dc:contributor>
<dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-05-05T16:02:32Z</dcterms:available>
<void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
<dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
</rdf:Description>
</rdf:RDF>
